Who owns CNS PHARMACEUTICALS INC?
- Ticker: CNSP
- CUSIP Number: 18978h300
Tip: Access positions for across all investors
Analyze quarterly positions in Cns Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Cns Pharmaceuticals stock
Who bought or sold CNS PHARMACEUTICALS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Geode Capital Management | 203k | $27k | 100% | Sep 2024 |
|
UBS Group | 182k | $24k | 6818% | Sep 2024 |
|
Virtu Financial | 123k | $16k | 100% | Sep 2024 |
|
Goldman Sachs Group | 28k | $3.7k | 100% | Sep 2024 |
|
Jane Street | 23k | $3.0k | 100% | Sep 2024 |
|
Tower Research Capital | 16k | $2.1k | 14072% | Sep 2024 |
|
Bank of America Corporation | 234.00 | $29.998800 | 23300% | Sep 2024 |
|
Wells Fargo & Company | 4.00 | $1.000000 | 0% | Sep 2024 |
|
Global Retirement Partners | 2.00 | $0 | 0% | Sep 2024 |
|
Northwestern Mutual Wealth Management Company | 1.00 | $0 | 100% | Sep 2024 |
|
Plante Moran Financial Advisors | 1.00 | $0 | 0% | Sep 2024 |
|
Parallel Advisors | 1.00 | $0 | 0% | Sep 2024 |
|
Who sold out of Cns Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Frigate Ventures | Jun 2024 | 141k | $223k |
Aspire Private Capital | Sep 2024 | 400.00 | $52.000000 |
FMR | Jun 2024 | 1.00 | $2.000000 |